Summary

Researchers at the University of Cambridge and the Early Cancer Institute have developed a groundbreaking urine test that may detect lung cancer in its earliest stages.

The test identifies proteins released by “zombie” cells, which are damaged cells that promote cancer development.

Using an injectable sensor, the test releases a detectable compound into urine, which changes color when exposed to a silver solution.

This affordable alternative to scans aims to diagnose lung cancer months or years before symptoms emerge, potentially improving survival rates for the world’s deadliest cancer. Human trials are anticipated soon.